Although some inter-experiment variability was observed for the absolute levels of senescence, hTRM9L-expressing tumour nodules were consistently higher in SA-β-Gal activity and peaked 3 days after in vivo inoculation. The gene discussed is TRMT9B; the disease is neoplasm.